Literature DB >> 4920226

Comparative trial of tetracycline, chloramphenicol, and trimethoprim-sulphamethoxazole in eradication of Vibrio cholerae El Tor.

R A Gharagozloo, K Naficy, M Mouin, M H Nassirzadeh, R Yalda.   

Abstract

A comparison of tetracycline, chloramphenicol, and trimethoprim/sulphamethoxazole showed that all hasten the eradication of Vibrio cholerae from the stools of patients with cholera.A four-day period of tetracycline or trimethoprim/ sulphamethoxazole was adequate for eradicating V. cholerae from the stools of all patients, but three days, as suggested by the W.H.O. Expert Committee, was not. Four days of chloramphenicol therapy was sufficient for most patients, but a minority required up to seven days' therapy.Purging produced reappearance of V. cholerae in the stools of one-eighth of the patients who had had three successive daily negative stool cultures; such patients are a potential danger to the population.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4920226      PMCID: PMC1819789          DOI: 10.1136/bmj.4.5730.281

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  THE MANAGEMENT OF EPIDEMIC CHOLERA.

Authors:  R S GORDON; W B GREENOUGH; J LINDENBAUM
Journal:  Mil Med       Date:  1965-05       Impact factor: 1.437

2.  Detection of Vibrio cholerae biotype El Tor by purging.

Authors:  E J Gangarosa; H Saghari; J Emile; H Siadat
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

  2 in total
  6 in total

1.  Sulphamethoxazole-trimethoprim: the first two years.

Authors:  D S Reeves
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

2.  In vitro susceptibility of El Tor and classical Vibrio cholerae strains to trimethoprim and sulfamethoxazole.

Authors:  R S Northrup; M A Doyle; J C Feeley
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

Review 3.  Antimicrobial drugs for treating cholera.

Authors:  Ya'ara Leibovici-Weissman; Ami Neuberger; Roni Bitterman; David Sinclair; Mohammed Abdus Salam; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2014-06-19

Review 4.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 5.  Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis.

Authors:  Ludovic Reveiz; Evelina Chapman; Pilar Ramon-Pardo; Tracey Perez Koehlmoos; Luis Gabriel Cuervo; Sylvain Aldighieri; Amy Chambliss
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

6.  Bovine Lactoferrin and Lactoferrin-Derived Peptides Inhibit the Growth of Vibrio cholerae and Other Vibrio species.

Authors:  Erika Acosta-Smith; Karina Viveros-Jiménez; Adrian Canizalez-Román; Magda Reyes-Lopez; Jan G M Bolscher; Kamran Nazmi; Hector Flores-Villaseñor; Gerardo Alapizco-Castro; Mireya de la Garza; Jesús J Martínez-Garcia; Jorge Velazquez-Roman; Nidia Leon-Sicairos
Journal:  Front Microbiol       Date:  2018-01-11       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.